* This system has been confirmed to work with [Google Chrome], [Microsoft Edge], and [Safari]. Please do not use any other browser. Note 1: Safari can be used with ver.2.0.3 (417.9.2) or later versions. Versions less than the above cannot be used. Note 2: For security reasons, if you do not proceed to the next screen within 120 minutes, the session will time out.
This site has obtained a server certificate issued by DigiCert, Inc.
We protect your information by SSL encrypted communication.
How SSL Secures You

First Author Name

※
If you are a non-member, please enter "88888".
※
※
First Name
Middle Name
Last/Surname

First Author Occupation ※

First Author Gender ※

First Author Affiliation Agency Information

※
※
※

First Author Affiliation Address Information

※
Example: 1-1-1 Kasumigaseki, Chiyoda-ku, Tokyo 123-4567, Japan
※
Please include "-" (hyphen)
Please include "-" (hyphen)

First Author Email Address ※

※

Affiliation Agency Information

Affiliation No.2
※
※
Affiliation No.3
※
※
Affiliation No.4
※
※

Co-author’s Information

First Author Affiliation Number
Co-Author Order Name Affiliation Number
Sample ※

※


※
Co-Author 1
※

※

※
Co-Author 2
※

※

※
Co-Author 3
※

※

※

Presentation Style ※

＊If you select A or F of research categories below and want to present at the JDS session, you must provide the ethical approval.

The presentation style will be decided by the Cairman and the Scientific Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

Topic Category

※
※

Research categories

Please choose a research category and provide ethical information.
 If you have any inquiries, please do not hesitate to contact us by e-mail. 
(E-mail: p-69jds@convention.co.jp) 

Requirement ※

【1】The study involves no use of medications for a research objective, including off-labeled or unapproved uses.
【2】The study involves no medical procedure which is not covered by health insurance.
【3】The study involves no invasive imaging procedure or tissue sampling, including any additional blood sampling, for a research objective.
【4】The study involves no questionnaire survey on study patients as a research objective.

Institution where the research was carried out is

If you chose A or F, you need to select "in Japan" or "not in Japan".

Institutional review status ※

All research in the abstract carried out in the institution in Japan defined as “A. Basic research involving hum an specimens” or “F. Clinical research/epidemiological surveys” should be obtained the ethical approval. ＊From this Meeting, you need to pass the ethical review when you submit your abstract. Without the approval of ethical review, you can not submit your abstract.

Institutional review status

Name of the institutional review board (IRB) ※

Name of the institutional review board (IRB)

Ethical approval number ※

Ethical approval number

Keyword

※

Title ※

Enter within 120 characters including spaces.
 

Abstract Body for Peer Review ※

Enter within 2,200characters including spaces .
*Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.

Type your abstract in the box below. You may also paste text processed offline into the box.

Follow the instructions below for special characters.
If you want to include symbols or Greek letters, type the respective code indicated in the tables at the position where you want to place it, or copy the code and paste it in the position.

If you want to use superscripts, subscripts, italics, bold, or underlines, follow the instructions below.

 

Symbols
When using the following symbols, please copy this field and paste it into the necessary place in the body of the abstract.
 
What to enter Na<SUP>+</SUP> H<SUB>2</SUB>O  <I>c-fos</I>  <B>Bold</B>  <U>Underline</U>  &gt; &lt;
What to appear Na+ H2O c-fos Bold Underline > <
 
 
Superscript
Enclose the text before and after with <SUP> and </SUP>.
Example: Na<SUP>+</SUP> for Na+
 
Subscript
Enclose the characters before and after with <SUB> and </SUB>.
Example: H<SUB>2</SUB>O for H2O
 
Italic
Enclose the text before and after with <I> and </I>.
Example: <I>c-fos</I> for c-fos
 
Bold
Enclose <B> and </B> before and after the text.
Example: <B>Bold</B> for Bold
 
Underline
Enclose <U> and </U> before and after the characters.
Example: <U>Underline</U> for Underline
 
"<" or ">" (greater than and less than signs)
Type "&lt;" for < and "&gt;" for > instead.
Example: p&lt;0.05

 

If you wish to use symbols, please refer to the character code table here and copy and paste the input code.


Affiliation name (co-author) is counted when the first author or the target institution number of the co-author is selected.
Subject Information
:0Count
Title
:0Count
Abstract Body
:0Count
Total
:0Count
※

Abstract Body for Abstract Book ※

Abstract Body for Abstract book: within 750 characters. (Including spaces)

Travel Grant ※

The Organizing Committee offers the travel grants for outstanding young investigators, healthcare professionals and students based on their peer review of the submitted abstracts.

Date of Birth ※

Travel Support ※

The Organizing Committee offers the travel supports for young investigators, healthcare professionals and students based on their peer review of abstracts, essays for motivation of participation, and recommendation of letter from his or her supervisor.
As for eligibility, please see our website: https://site.convention.co.jp/69jds/en/abstract/

Date of Birth ※

Letter of Motivation Upload ※

Recommendation Letter Upload ※

CV File Upload ※

COI Information

Please declare if any of the presenters or their family members have the conflicts of interest listed below related to the submitting abstracts in the past three years.
First Author
Item Conflict?※ If yes, enter the company name, details, etc.
1 (1)
Remuneration of Board or advisors
(Disclose if remuneration exceeds 1,000,000 yen from a single company or for-profit organization.) 		Author
Spouse, Relatives, etc.
2 (2)
Stocks
(Disclose if stock profit exceeds 1,000,000 yen annually from a single company, or if ownership is 5% or more of total shares.) 		Author
Spouse, Relatives, etc.
3 (3)
Patent royalties
(Disclose if royalties or licensing fees exceeds 1,000,000 yen per year for a single patent.) 		Author
Spouse, Relatives, etc.
4 (4)
Honoraria (lecture fees)
(Disclose amount if annual honoraria from a single company or organization exceeds 500,000 yen) 		Author
5 (5)
Manuscript fees
(Disclose amount if annual manuscript fees from a single company or organization exceeds 500,000 yen) 		Author
6 (6)
Research funds
(Disclose if research funding from a single company or organization allocated for medical science research (joint research, commissioned research, clinical trials etc.) exceeds 1,000,000 yen annually which the discloser can practically decide how to spend) 		Author
7 (7)
Scholarship grants
(Give amount if scholarship (incentive) donations provided by a single company or organization to the affiliated department or division allocated for use exceeds 1,000,000 yen annually which the discloser can practically decide how to spend) 		Author
8 (8)
Endowed department funded by companies, etc
(Disclose if funding allocated for research exceeds 1,000,000 yen annually which the discloser can practically decide how to spend) 		Author
9 (9)
Travel expenses, gifts etc
(Disclose if annual remuneration received from a single company or organization exceeds 50,000 yen) 		Author
10 (10)
[Institution]
Other remuneration
(Disclose if the research institute to which the discloser belongs or the head of the institute or department holds shares, royalties, investments, etc., in companies related to the business activities of the Society exceeds 1 million yen from one company or if ownership is 5% or more of total shares annualy) 		Author
11 (11)
[Institution]
Research funds
(Give amount if the research grant from a single company or organization for medical research (joint research, commissioned research, clinical trials, etc.) exceeds 10 million yen annually, the total amount of which the discloser can practically decide how to spend.) 		Author
12 (12)
[Institution]
Scholarship grants
(Disclose if scholarship (incentive) donations provided by a single company or organization for medical research (joint research, commissioned research, clinical trials, etc.) exceeds 2,000,000 yen annually, the total amount of which the discloser can practically decide how to spend.) 		Author

Password ※

Password must contain at least 6 characters, including at least one lowercase alphabet and one number.
You will need your reception number and password to check and correct your abstract, so make a note of these two displayed on the registration completion screen. Please be sure to fill in the question items displayed with *. Registration cannot be completed if there is no input. Please fill in the required questions and then click the "Next" button.
Click here to create entry  
congress secretariat of 69JDS
p-69jds@convention.co.jp